{"id":38683,"date":"2021-06-22T13:29:29","date_gmt":"2021-06-22T12:29:29","guid":{"rendered":"https:\/\/copleyv3.fifteen.dev\/news-events\/copley-scientific-joins-the-industries-forum-of-the-taskforce-for-lung-health-2\/"},"modified":"2022-09-28T13:14:50","modified_gmt":"2022-09-28T12:14:50","slug":"copley-scientific-joins-the-industries-forum-of-the-taskforce-for-lung-health-2","status":"publish","type":"post","link":"https:\/\/www.copleyscientific.com\/zh-hans\/news-events\/copley-scientific-joins-the-industries-forum-of-the-taskforce-for-lung-health-2\/","title":{"rendered":"Copley Scientific joins the Industries Forum of the Taskforce for Lung Health"},"content":{"rendered":"<div class=\"entry-content\"><p><strong><u>23\u00a0June 2021; Nottingham, UK<\/u><\/strong><strong>:<\/strong> Copley Scientific has joined the Industries Forum of the Taskforce for Lung Health. The Taskforce is a collaboration of over 30 members including patients, health care professionals, the voluntary sector and professional associations all working together to represent the needs of people with lung disease. The Taskforce\u2019s Industries Forum is a group of representatives from the pharmaceutical, diagnostics, devices, and digital industries that works alongside the Taskforce to improve the diagnosis, treatment, and care of patients living with lung disease in England. Company experts will join regular meetings of the Industries Forum to share relevant industry views, intelligence, and experience. As the world\u2019s leading manufacturer and supplier of inhaler test equipment, Copley brings unique perspective on the safety and quality issues associated with inhaler testing and use.<\/p>\n<p>The Taskforce has established a five-year plan to improve all aspects of lung disease management from the preservation of good lung health, through to earlier, more effective disease diagnosis, and end of life care. Working groups focusing on Early Diagnosis, Medicines Optimisation, and Pulmonary Rehabilitation, help to implement the associated recommendations of the five year plan. These groups draw on a wide range of expertise from the Taskforce and the Industries Forum to ensure optimal solutions to some of the most demanding challenges associated with lung health.<\/p>\n<p>Copley, a family-owned UK company currently celebrating 75 years in business, develops and manufactures equipment for <em>in vitro<\/em> inhaler testing that is used to optimise the safety and efficacy of drugs for conditions such as asthma, COPD, and cystic fibrosis. Developing solutions that make <em>in vitro<\/em> testing more clinically representative is currently an important task, and a good example of the insight that Copley has to offer. Such solutions help researchers to efficiently build an increasingly accurate and detailed understanding of how to improve inhaled drug delivery and how patient physiology and technique impact its success. This knowledge informs better device design for specific patient groups and a more robust assessment of the potential for inadequate drug delivery, where technique is compromised.<\/p>\n<p>\u201cWe\u2019re looking forward to investing in the very worthwhile work of the Taskforce for Lung Health,\u201d said Mr Mark Copley, CEO, Copley Scientific. \u201cLung health is currently at the forefront of people\u2019s minds, and I hope we can help to make real progress in patient outcomes. Copley occupies a distinctive position within the inhaled product research community, and we\u2019re pleased to be able to contribute our insight and expertise to more directly support lung disease sufferers across England.\u201d<\/p>\n<p>Learn more about the work of the Taskforce, here: <strong><span style=\"color: #418fde;\"><a style=\"color: #418fde;\" href=\"https:\/\/www.blf.org.uk\/taskforce\">https:\/\/www.blf.org.uk\/taskforce<\/a><\/span><\/strong><\/p>\n<p style=\"text-align: center;\"><a href=\"https:\/\/www.blf.org.uk\/taskforce\" target=\"_blank\" rel=\"noopener\"><img decoding=\"async\" class=\"alignnone size-full wp-image-14161\" src=\"https:\/\/www.copleyscientific.com\/wp-content\/smush-webp\/2021\/06\/TF-e1624364277750.png.webp\" alt=\"We support the Taskforce plan for Lung Health\" loading=\"lazy\" \/><\/a><\/p>\n<p style=\"text-align: center;\"><strong>CAPTION: Copley is proud to announce joining the Taskforce for Lung Health as its newest Industries Forum member.<\/strong><\/p>\n<p style=\"text-align: center;\"><strong>ENDS<\/strong><\/p>\n<p>&nbsp;<\/p>\n<h3><strong>About Copley Scientific<\/strong><\/h3>\n<p>Copley Scientific is widely recognised as the world\u2019s leading manufacturer and supplier of inhaler test equipment and is a major provider of testing systems for other pharmaceutical dosage forms. The company also supplies equipment for detergent testing.<\/p>\n<p>Copley\u2019s pharmaceutical product range includes test equipment for all types of orally inhaled and nasal drug products &#8211; metered-dose inhalers, dry powder inhalers, nebulisers and nasal sprays &#8211; with a particular focus on solutions for delivered dose uniformity and aerodynamic particle size distribution measurement. It also includes testers for tablets (dissolution, disintegration, friability and hardness) capsules, powders, suppositories, semisolids and transdermals.<\/p>\n<p>Used from R&amp;D through to QC, this extensive range of equipment is supported by a full validation and aftersales service. Copley Scientific has offices in the UK and Switzerland and works in partnership with aerosol particle science experts MSP Corporation in North America; specialist distributors extend localised support across the world. This network provides expert help and training to every customer, directly enhancing the application of all Copley products.\u00a0 <a href=\"http:\/\/www.copleyscientific.com\">www.copleyscientific.com<\/a><\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"23\u00a0June 2021; Nottingham, UK: Copley Scientific has joined the Industries Forum of the Taskforce for Lung Health. The Taskforce is a collaboration of over 30 members including patients, health care professionals, the voluntary sector and professional associations all working together to represent the needs of people with lung disease. The Taskforce\u2019s Industries Forum is a&#8230; <br><a class=\"view-article\" href=\"https:\/\/www.copleyscientific.com\/zh-hans\/news-events\/copley-scientific-joins-the-industries-forum-of-the-taskforce-for-lung-health-2\/\">View Article<\/a>","protected":false},"author":1,"featured_media":38684,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[200,202],"tags":[270,325,324,323,322,312,308,307,303,295,282,277,274,272,271,179,257,256,255,254,253,249,248,236,235,234,232,221,182],"class_list":["post-38683","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-200","category-corporate-zh-hans","tag-vertus-plus-zh-hans","tag-ddu-nasal-powders-zh-hans-2","tag-ddu-nasal-aerosols-zh-hans-3","tag-apsd-nasal-powders-zh-hans-3","tag-apsd-nasal-aerosols-zh-hans-3","tag-brs-1100-zh-hans-2","tag-ddu-nasal-sprays-zh-hans-2","tag-apsd-nasal-sprays-zh-hans-2","tag-ddu-aqueous-drop-inhalers-adis-zh-hans-2","tag-ddu-facemask-testing-zh-hans-3","tag-ddu-ivivc-mdis-bais-dpis-nebulisers-zh-hans-2","tag-apsd-nebulisers-zh-hans-3","tag-ddu-dry-powder-inhalers-dpis-zh-hans","tag-vertus-ii-zh-hans-2","tag-decavertus-ii-zh-hans-2","tag-tpk","tag-gentle-rocker-zh-hans","tag-ngi-assistant-zh-hans-2","tag-255","tag-spu-2000-zh-hans-2","tag-tpk-zh-hans-2","tag-tpk-2100-zh-hans-2","tag-usp-monographs-generic-drug-development-albuterol-zh-hans-2","tag-ddu-spacers-vhcs-zh-hans-2","tag-apsd-spacers-vhcs-zh-hans-3","tag-bac-2100-zh-hans-2","tag-cup-coater-ngi-zh-hans-2","tag-apsd-for-aqueous-droplet-inhalers-adis-zh-hans","tag-tpk-zh-hans"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Copley Scientific joins the Industries Forum of the Taskforce for Lung Health - Copley Scientific<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.copleyscientific.com\/zh-hans\/news-events\/copley-scientific-joins-the-industries-forum-of-the-taskforce-for-lung-health-2\/\" \/>\n<meta property=\"og:locale\" content=\"zh_CN\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Copley Scientific joins the Industries Forum of the Taskforce for Lung Health - Copley Scientific\" \/>\n<meta property=\"og:description\" content=\"23\u00a0June 2021; Nottingham, UK: Copley Scientific has joined the Industries Forum of the Taskforce for Lung Health. The Taskforce is a collaboration of over 30 members including patients, health care professionals, the voluntary sector and professional associations all working together to represent the needs of people with lung disease. The Taskforce\u2019s Industries Forum is a... View Article\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.copleyscientific.com\/zh-hans\/news-events\/copley-scientific-joins-the-industries-forum-of-the-taskforce-for-lung-health-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Copley Scientific\" \/>\n<meta property=\"article:published_time\" content=\"2021-06-22T12:29:29+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-09-28T12:14:50+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.copleyscientific.com\/wp-content\/uploads\/2021\/06\/TF-e1624436616910-1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"567\" \/>\n\t<meta property=\"og:image:height\" content=\"274\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"fifteen\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"fifteen\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Copley Scientific joins the Industries Forum of the Taskforce for Lung Health - Copley Scientific","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.copleyscientific.com\/zh-hans\/news-events\/copley-scientific-joins-the-industries-forum-of-the-taskforce-for-lung-health-2\/","og_locale":"zh_CN","og_type":"article","og_title":"Copley Scientific joins the Industries Forum of the Taskforce for Lung Health - Copley Scientific","og_description":"23\u00a0June 2021; Nottingham, UK: Copley Scientific has joined the Industries Forum of the Taskforce for Lung Health. The Taskforce is a collaboration of over 30 members including patients, health care professionals, the voluntary sector and professional associations all working together to represent the needs of people with lung disease. The Taskforce\u2019s Industries Forum is a... View Article","og_url":"https:\/\/www.copleyscientific.com\/zh-hans\/news-events\/copley-scientific-joins-the-industries-forum-of-the-taskforce-for-lung-health-2\/","og_site_name":"Copley Scientific","article_published_time":"2021-06-22T12:29:29+00:00","article_modified_time":"2022-09-28T12:14:50+00:00","og_image":[{"width":567,"height":274,"url":"https:\/\/www.copleyscientific.com\/wp-content\/uploads\/2021\/06\/TF-e1624436616910-1.png","type":"image\/png"}],"author":"fifteen","twitter_card":"summary_large_image","twitter_misc":{"Written by":"fifteen","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.copleyscientific.com\/zh-hans\/news-events\/copley-scientific-joins-the-industries-forum-of-the-taskforce-for-lung-health-2\/#article","isPartOf":{"@id":"https:\/\/www.copleyscientific.com\/zh-hans\/news-events\/copley-scientific-joins-the-industries-forum-of-the-taskforce-for-lung-health-2\/"},"author":{"name":"fifteen","@id":"https:\/\/www.copleyscientific.com\/#\/schema\/person\/91b846caa5fc98ce157439466ff2600c"},"headline":"Copley Scientific joins the Industries Forum of the Taskforce for Lung Health","datePublished":"2021-06-22T12:29:29+00:00","dateModified":"2022-09-28T12:14:50+00:00","mainEntityOfPage":{"@id":"https:\/\/www.copleyscientific.com\/zh-hans\/news-events\/copley-scientific-joins-the-industries-forum-of-the-taskforce-for-lung-health-2\/"},"wordCount":644,"image":{"@id":"https:\/\/www.copleyscientific.com\/zh-hans\/news-events\/copley-scientific-joins-the-industries-forum-of-the-taskforce-for-lung-health-2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.copleyscientific.com\/wp-content\/uploads\/2021\/06\/TF-e1624436616910-1.png","keywords":["Vertus Plus","DDU Nasal Powders","DDU Nasal Aerosols","APSD Nasal Powders","APSD Nasal Aerosols","BRS 1100","DDU Nasal Sprays","APSD Nasal Sprays","DDU Aqueous Drop Inhalers (ADIs)","DDU Facemask Testing","DDU IVIVC (MDIs\/BAIs\/DPIs &amp; Nebulisers)","APSD Nebulisers","DDU Dry Powder Inhalers (DPIs)","Vertus II","DecaVertus II","TPK","Gentle Rocker","NGI Assistant","\u51b2\u51fb\u5668\u6e05\u6d01\u88c5\u7f6e","SPU 2000","TPK","TPK 2100","USP Monographs (Generic Drug Development) Albuterol","DDU Spacers\/VHCs","APSD Spacers\/VHCs","BAC 2100","Cup Coater (NGI)","APSD for Aqueous Droplet Inhalers (ADIs)","TPK"],"articleSection":["\u5438\u5165\u5236\u5242\u8bd5\u9a8c","\u516c\u53f8"],"inLanguage":"zh-CN"},{"@type":"WebPage","@id":"https:\/\/www.copleyscientific.com\/zh-hans\/news-events\/copley-scientific-joins-the-industries-forum-of-the-taskforce-for-lung-health-2\/","url":"https:\/\/www.copleyscientific.com\/zh-hans\/news-events\/copley-scientific-joins-the-industries-forum-of-the-taskforce-for-lung-health-2\/","name":"Copley Scientific joins the Industries Forum of the Taskforce for Lung Health - Copley Scientific","isPartOf":{"@id":"https:\/\/www.copleyscientific.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.copleyscientific.com\/zh-hans\/news-events\/copley-scientific-joins-the-industries-forum-of-the-taskforce-for-lung-health-2\/#primaryimage"},"image":{"@id":"https:\/\/www.copleyscientific.com\/zh-hans\/news-events\/copley-scientific-joins-the-industries-forum-of-the-taskforce-for-lung-health-2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.copleyscientific.com\/wp-content\/uploads\/2021\/06\/TF-e1624436616910-1.png","datePublished":"2021-06-22T12:29:29+00:00","dateModified":"2022-09-28T12:14:50+00:00","author":{"@id":"https:\/\/www.copleyscientific.com\/#\/schema\/person\/91b846caa5fc98ce157439466ff2600c"},"breadcrumb":{"@id":"https:\/\/www.copleyscientific.com\/zh-hans\/news-events\/copley-scientific-joins-the-industries-forum-of-the-taskforce-for-lung-health-2\/#breadcrumb"},"inLanguage":"zh-CN","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.copleyscientific.com\/zh-hans\/news-events\/copley-scientific-joins-the-industries-forum-of-the-taskforce-for-lung-health-2\/"]}]},{"@type":"ImageObject","inLanguage":"zh-CN","@id":"https:\/\/www.copleyscientific.com\/zh-hans\/news-events\/copley-scientific-joins-the-industries-forum-of-the-taskforce-for-lung-health-2\/#primaryimage","url":"https:\/\/www.copleyscientific.com\/wp-content\/uploads\/2021\/06\/TF-e1624436616910-1.png","contentUrl":"https:\/\/www.copleyscientific.com\/wp-content\/uploads\/2021\/06\/TF-e1624436616910-1.png","width":567,"height":274},{"@type":"BreadcrumbList","@id":"https:\/\/www.copleyscientific.com\/zh-hans\/news-events\/copley-scientific-joins-the-industries-forum-of-the-taskforce-for-lung-health-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.copleyscientific.com\/zh-hans\/"},{"@type":"ListItem","position":2,"name":"Copley Scientific joins the Industries Forum of the Taskforce for Lung Health"}]},{"@type":"WebSite","@id":"https:\/\/www.copleyscientific.com\/#website","url":"https:\/\/www.copleyscientific.com\/","name":"Copley Scientific","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.copleyscientific.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"zh-CN"},{"@type":"Person","@id":"https:\/\/www.copleyscientific.com\/#\/schema\/person\/91b846caa5fc98ce157439466ff2600c","name":"fifteen","image":{"@type":"ImageObject","inLanguage":"zh-CN","@id":"https:\/\/secure.gravatar.com\/avatar\/90a7aefe9a61edd78fd2f3a689184af548768d9da2fd48656f39a6b7b575a237?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/90a7aefe9a61edd78fd2f3a689184af548768d9da2fd48656f39a6b7b575a237?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/90a7aefe9a61edd78fd2f3a689184af548768d9da2fd48656f39a6b7b575a237?s=96&d=mm&r=g","caption":"fifteen"},"sameAs":["http:\/\/localhost:8888\/copley-v3"],"url":"https:\/\/www.copleyscientific.com\/zh-hans\/news-events\/author\/fifteen\/"}]}},"_links":{"self":[{"href":"https:\/\/www.copleyscientific.com\/zh-hans\/wp-json\/wp\/v2\/posts\/38683","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.copleyscientific.com\/zh-hans\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.copleyscientific.com\/zh-hans\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.copleyscientific.com\/zh-hans\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.copleyscientific.com\/zh-hans\/wp-json\/wp\/v2\/comments?post=38683"}],"version-history":[{"count":0,"href":"https:\/\/www.copleyscientific.com\/zh-hans\/wp-json\/wp\/v2\/posts\/38683\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.copleyscientific.com\/zh-hans\/wp-json\/wp\/v2\/media\/38684"}],"wp:attachment":[{"href":"https:\/\/www.copleyscientific.com\/zh-hans\/wp-json\/wp\/v2\/media?parent=38683"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.copleyscientific.com\/zh-hans\/wp-json\/wp\/v2\/categories?post=38683"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.copleyscientific.com\/zh-hans\/wp-json\/wp\/v2\/tags?post=38683"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}